Allogeneic bone marrow-derived human mesenchymal stem cells (University Hospital Tubingen)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameAllogeneic bone marrow-derived human mesenchymal stem cells (University Hospital Tubingen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Tubingen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Hospital Tubingen
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A